{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T04:00:54Z","timestamp":1790740854881,"version":"4.1.0"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T00:00:00Z","timestamp":1784764800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005054","name":"Nantong University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Translational Oncology"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.tranon.2026.102932","type":"journal-article","created":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T16:18:35Z","timestamp":1785255515000},"page":"102932","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Lung cancer stem cells in the tumor microenvironment: translational biomarkers and therapeutic strategies for immune evasion and treatment resistance"],"prefix":"10.1016","volume":"72","author":[{"given":"Li Li","family":"Shao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing Jing","family":"Shao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tian Ye","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Er Dong","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaxuan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ru Jian","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sai Hua","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tranon.2026.102932_bib0001","article-title":"Neoadjuvant immunotherapy for lung cancer: current limitations and future prospects","volume":"17","author":"Yang","year":"2026","journal-title":"Front. Immunol."},{"key":"10.1016\/j.tranon.2026.102932_bib0002","article-title":"Diagnostic value of exosome-derived lncRNA PITPNA-AS1 in lung cancer","volume":"16","author":"Chen","year":"2025","journal-title":"Front. Immunol."},{"key":"10.1016\/j.tranon.2026.102932_bib0003","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2026.218382","article-title":"Immunotherapy for extensive-stage small cell lung cancer: current status, challenges and future strategies","volume":"645","author":"Yan","year":"2026","journal-title":"Cancer Lett."},{"key":"10.1016\/j.tranon.2026.102932_bib0004","doi-asserted-by":"crossref","DOI":"10.1016\/j.tranon.2026.102755","article-title":"Circulating low-density neutrophils as biomarkers of resistance to first-line anti-PD-1\/PD-L1 immunotherapy in non-small cell lung cancer","volume":"67","author":"Castro","year":"2026","journal-title":"Transl. Oncol."},{"key":"10.1016\/j.tranon.2026.102932_bib0005","article-title":"Identification of cancer stem cell-related genes through single cells and machine learning for predicting prostate cancer prognosis and immunotherapy","volume":"15","author":"Wang","year":"2024","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.tranon.2026.102932_bib0006","doi-asserted-by":"crossref","DOI":"10.1080\/15384047.2025.2450849","article-title":"Effect of extracellular vesicle ZNF280B derived from lung cancer stem cells on lung cancer progression","volume":"26","author":"Guo","year":"2025","journal-title":"Cancer Biol. Ther."},{"key":"10.1016\/j.tranon.2026.102932_bib0007","first-page":"57","article-title":"Elucidating the role of FASN in lung cancer stem cells in sensitive and resistant EGFR-mutated non-small cell lung cancer cells","volume":"16","author":"Polonio-Alcal\u00e1","year":"2025","journal-title":"Lung Cancer (Auckl)"},{"key":"10.1016\/j.tranon.2026.102932_bib0008","doi-asserted-by":"crossref","DOI":"10.1016\/j.tranon.2023.101778","article-title":"Histone demethylase KDM6A coordinating with KMT2B regulates self-renewal and chemoresistance of non-small cell lung cancer stem cells","volume":"37","author":"Chen","year":"2023","journal-title":"Transl. Oncol."},{"issue":"4","key":"10.1016\/j.tranon.2026.102932_bib0009","doi-asserted-by":"crossref","DOI":"10.1002\/cam4.71868","article-title":"Effects of tumor microenvironment on lung cancer stem cells: bidirectional regulatory mechanisms","volume":"15","author":"Lai","year":"2026","journal-title":"Cancer Med."},{"key":"10.1016\/j.tranon.2026.102932_bib0010","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.critrevonc.2018.02.015","article-title":"Current perspectives on the crosstalk between lung cancer stem cells and cancer-associated fibroblasts","volume":"125","author":"Alguacil-N\u00fa\u00f1ez","year":"2018","journal-title":"Crit. Rev. Oncol. Hematol."},{"issue":"1","key":"10.1016\/j.tranon.2026.102932_bib0011","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/s12943-023-01748-4","article-title":"Cross-talk between cancer stem cells and immune cells: potential therapeutic targets in the tumor immune microenvironment","volume":"22","author":"Wu","year":"2023","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.tranon.2026.102932_bib0012","first-page":"9","article-title":"Cancer stem cells: progress and challenges in lung cancer","volume":"1","author":"Templeton","year":"2014","journal-title":"Stem Cell Investig."},{"issue":"7","key":"10.1016\/j.tranon.2026.102932_bib0013","doi-asserted-by":"crossref","first-page":"1975","DOI":"10.4049\/jimmunol.1701727","article-title":"Three-dimensional ameliorated biologics elicit thymic renewal in tumor-bearing hosts","volume":"201","author":"Zhang","year":"2018","journal-title":"J. Immunol."},{"issue":"12","key":"10.1016\/j.tranon.2026.102932_bib0014","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.1111\/1440-1681.13572","article-title":"Melatonin and its derivative disrupt cancer stem-like phenotypes of lung cancer cells via AKT downregulation","volume":"48","author":"Phiboonchaiyanan","year":"2021","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"issue":"2","key":"10.1016\/j.tranon.2026.102932_bib0015","first-page":"111","article-title":"Lung cancer stem-like cells and drug resistance","volume":"25","author":"Pan","year":"2022","journal-title":"Zhongguo Fei. Ai. Za Zhi."},{"issue":"1","key":"10.1016\/j.tranon.2026.102932_bib0016","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.bbrc.2016.11.038","article-title":"Wnt\/\u03b2-catenin pathway mediates (-)-Epigallocatechin-3-gallate (EGCG) inhibition of lung cancer stem cells","volume":"482","author":"Zhu","year":"2017","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"1","key":"10.1016\/j.tranon.2026.102932_bib0017","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1186\/s13046-024-02989-x","article-title":"IL6-STAT3-C\/EBP\u03b2-IL6 positive feedback loop in tumor-associated macrophages promotes the EMT and metastasis of lung adenocarcinoma","volume":"43","author":"Hu","year":"2024","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"2","key":"10.1016\/j.tranon.2026.102932_bib0018","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1007\/s12015-018-9860-7","article-title":"PD-L1 Expression on lung cancer stem cells in metastatic lymph nodes aspirates","volume":"15","author":"Raniszewska","year":"2019","journal-title":"Stem Cell Rev. Rep."},{"issue":"5","key":"10.1016\/j.tranon.2026.102932_bib0019","first-page":"6791","article-title":"Utilization of lung cancer cell lines for the study of lung cancer stem cells","volume":"15","author":"Wang","year":"2018","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.tranon.2026.102932_bib0020","article-title":"Lung cancer stem cell markers as therapeutic targets: an update on signaling pathways and therapies","volume":"12","author":"Zheng","year":"2022","journal-title":"Front. Oncol."},{"issue":"1","key":"10.1016\/j.tranon.2026.102932_bib0021","doi-asserted-by":"crossref","first-page":"575","DOI":"10.3892\/mmr.2020.11113","article-title":"Effect of SIRT1 activators and inhibitors on CD44+\/CD133+\u2011enriched non\u2011small cell lung cancer cells","volume":"22","author":"Eroglu","year":"2020","journal-title":"Mol. Med. Rep."},{"issue":"3","key":"10.1016\/j.tranon.2026.102932_bib0022","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.cllc.2019.02.005","article-title":"Cancer stem cell biomarkers in EGFR-mutation-positive non-small-cell lung cancer","volume":"20","author":"Codony-Servat","year":"2019","journal-title":"Clin. Lung Cancer"},{"issue":"8","key":"10.1016\/j.tranon.2026.102932_bib0023","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1517\/14728222.2016.1154945","article-title":"Wnt signaling as potential therapeutic target in lung cancer","volume":"20","author":"Yang","year":"2016","journal-title":"Expert. Opin. Ther. Targets."},{"issue":"8","key":"10.1016\/j.tranon.2026.102932_bib0024","doi-asserted-by":"crossref","first-page":"10383","DOI":"10.1007\/s13277-016-4928-y","article-title":"The effects and mechanisms of SLC34A2 on tumorigenicity in human non-small cell lung cancer stem cells","volume":"37","author":"Jiang","year":"2016","journal-title":"Tumour. Biol."},{"issue":"7","key":"10.1016\/j.tranon.2026.102932_bib0025","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.4103\/jcrt.JCRT_482_17","article-title":"Specific inhibition of Notch1 signaling suppresses properties of lung cancer stem cells","volume":"15","author":"Cai","year":"2019","journal-title":"J. Cancer Res. Ther."},{"issue":"16","key":"10.1016\/j.tranon.2026.102932_bib0026","doi-asserted-by":"crossref","first-page":"4827","DOI":"10.7150\/thno.33812","article-title":"Sulforaphane inhibits the acquisition of tobacco smoke-induced lung cancer stem cell-like properties via the IL-6\/\u0394Np63\u03b1\/notch axis","volume":"9","author":"Xie","year":"2019","journal-title":"Theranostics"},{"issue":"4","key":"10.1016\/j.tranon.2026.102932_bib0027","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1002\/ptr.5791","article-title":"Curcumin suppresses lung cancer stem cells via inhibiting Wnt\/\u03b2-catenin and sonic hedgehog pathways","volume":"31","author":"Zhu","year":"2017","journal-title":"PhytOther Res."},{"issue":"1","key":"10.1016\/j.tranon.2026.102932_bib0028","first-page":"109","article-title":"Sulforaphane reverses gefitinib tolerance in human lung cancer cells via modulation of sonic hedgehog signaling","volume":"15","author":"Wang","year":"2018","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.tranon.2026.102932_bib0029","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.02168","article-title":"CXCR4 inhibition counteracts immunosuppressive properties of metastatic NSCLC stem cells","volume":"11","author":"Fortunato","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.tranon.2026.102932_bib0030","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2026.1873649","article-title":"Editorial: new tumor immune checkpoints and their applications in tumor immunotherapy","volume":"13","author":"Zhang","year":"2026","journal-title":"Front. Mol. Biosci."},{"key":"10.1016\/j.tranon.2026.102932_bib0031","article-title":"Editorial: studying the immune microenvironment of liver cancer using artificial intelligence","volume":"16","author":"Zhang","year":"2025","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.tranon.2026.102932_bib0032","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1186\/s13045-020-00887-1","article-title":"Oct4 promotes M2 macrophage polarization through upregulation of macrophage colony-stimulating factor in lung cancer","volume":"13","author":"Lu","year":"2020","journal-title":"J. Hematol. Oncol."},{"issue":"2","key":"10.1016\/j.tranon.2026.102932_bib0033","doi-asserted-by":"crossref","DOI":"10.3892\/mmr.2021.12189","article-title":"Porcupine inhibitor LGK\u2011974 inhibits Wnt\/\u03b2\u2011catenin signaling and modifies tumor\u2011associated macrophages resulting in inhibition of the malignant behaviors of non\u2011small cell lung cancer cells","volume":"24","author":"Tang","year":"2021","journal-title":"Mol. Med. Rep."},{"issue":"26","key":"10.1016\/j.tranon.2026.102932_bib0034","doi-asserted-by":"crossref","first-page":"39363","DOI":"10.18632\/oncotarget.8101","article-title":"Modulation of macrophage polarization and lung cancer cell stemness by MUC1 and development of a related small-molecule inhibitor pterostilbene","volume":"7","author":"Huang","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.tranon.2026.102932_bib0035","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.molimm.2025.08.022","article-title":"SNHG16-loaded extracellular vesicles from hypoxic NSCLC cells drive M2 macrophage polarization to enhance cancer aggressiveness","volume":"187","author":"Hou","year":"2025","journal-title":"Mol. Immunol."},{"issue":"4","key":"10.1016\/j.tranon.2026.102932_bib0036","doi-asserted-by":"crossref","first-page":"68","DOI":"10.3892\/br.2024.1754","article-title":"Myeloid\u2011derived suppressor cell accumulation induces Treg expansion and modulates lung malignancy progression","volume":"20","author":"Wan","year":"2024","journal-title":"Biomed. Rep."},{"key":"10.1016\/j.tranon.2026.102932_bib0037","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2022.154307","article-title":"Total glucosides of paeony inhibit breast cancer growth by inhibiting TAMs infiltration through NF-\u03baB\/CCL2 signaling","volume":"104","author":"Jin","year":"2022","journal-title":"Phytomedicine"},{"issue":"6","key":"10.1016\/j.tranon.2026.102932_bib0038","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1007\/s10637-018-0628-3","article-title":"Proliferative CD8(+) PD-1(+) T-cell infiltration in a pembrolizumab-induced cutaneous adverse reaction","volume":"36","author":"Kunimasa","year":"2018","journal-title":"Invest. New Drugs"},{"issue":"8","key":"10.1016\/j.tranon.2026.102932_bib0039","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1016\/j.jtho.2022.05.014","article-title":"Targeting lysine-specific demethylase 1 rescues major histocompatibility complex class i antigen presentation and overcomes programmed death-ligand 1 blockade resistance in SCLC","volume":"17","author":"Nguyen","year":"2022","journal-title":"J. Thorac. Oncol."},{"issue":"4","key":"10.1016\/j.tranon.2026.102932_bib0040","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2022-004527","article-title":"Cancer stem-like cells evade CD8(+)CD103(+) tumor-resident memory T (T(RM)) lymphocytes by initiating an epithelial-to-mesenchymal transition program in a human lung tumor model","volume":"10","author":"Corgnac","year":"2022","journal-title":"J. ImmunOther Cancer"},{"issue":"1","key":"10.1016\/j.tranon.2026.102932_bib0041","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1186\/s13578-023-01158-5","article-title":"Musashi-2 in cancer-associated fibroblasts promotes non-small cell lung cancer metastasis through paracrine IL-6-driven epithelial-mesenchymal transition","volume":"13","author":"Samart","year":"2023","journal-title":"Cell Biosci."},{"issue":"1","key":"10.1016\/j.tranon.2026.102932_bib0042","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1186\/s12967-016-1091-6","article-title":"PDGF-AA mediates mesenchymal stromal cell chemotaxis to the head and neck squamous cell carcinoma tumor microenvironment","volume":"14","author":"Watts","year":"2016","journal-title":"J. Transl. Med."},{"issue":"5","key":"10.1016\/j.tranon.2026.102932_bib0043","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2021.109071","article-title":"Pharmacological Wnt ligand inhibition overcomes key tumor-mediated resistance pathways to anti-PD-1 immunotherapy","volume":"35","author":"DeVito","year":"2021","journal-title":"Cell Rep."},{"key":"10.1016\/j.tranon.2026.102932_bib0044","doi-asserted-by":"crossref","first-page":"404","DOI":"10.3389\/fimmu.2017.00404","article-title":"Anti-CD47 antibody as a targeted therapeutic agent for human lung cancer and cancer stem cells","volume":"8","author":"Liu","year":"2017","journal-title":"Front. Immunol."}],"container-title":["Translational Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1936523326002688?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1936523326002688?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T03:35:04Z","timestamp":1790739304000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1936523326002688"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":44,"alternative-id":["S1936523326002688"],"URL":"https:\/\/doi.org\/10.1016\/j.tranon.2026.102932","relation":{},"ISSN":["1936-5233"],"issn-type":[{"value":"1936-5233","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Lung cancer stem cells in the tumor microenvironment: translational biomarkers and therapeutic strategies for immune evasion and treatment resistance","name":"articletitle","label":"Article Title"},{"value":"Translational Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tranon.2026.102932","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"102932"}}